Journal article
Drebrin attenuates atherosclerosis by limiting smooth muscle cell transdifferentiation
Cardiovascular research, Vol.118(3), pp.772-784
02/21/2022
DOI: 10.1093/cvr/cvab156
PMCID: PMC8859638
PMID: 33914863
Abstract
The F-actin-binding protein Drebrin inhibits smooth muscle cell (SMC) migration, proliferation, and pro-inflammatory signalling. Therefore, we tested the hypothesis that Drebrin constrains atherosclerosis.
SM22-Cre+/Dbnflox/flox/Ldlr-/- (SMC-Dbn-/-/Ldlr-/-) and control mice (SM22-Cre+/Ldlr-/-, Dbnflox/flox/Ldlr-/-, and Ldlr-/-) were fed a western diet for 14-20 weeks. Brachiocephalic arteries of SMC-Dbn -/-/Ldlr-/- mice exhibited 1.5- or 1.8-fold greater cross-sectional lesion area than control mice at 14 or 20 weeks, respectively. Aortic atherosclerotic lesion surface area was 1.2-fold greater in SMC-Dbn-/-/Ldlr-/- mice. SMC-Dbn-/-/Ldlr-/- lesions comprised necrotic cores that were two-fold greater in size than those of control mice. Consistent with their bigger necrotic core size, lesions in SMC-Dbn-/- arteries also showed more transdifferentiation of SMCs to macrophage-like cells: 1.5- to 2.5-fold greater, assessed with BODIPY or with CD68, respectively. In vitro data were concordant: Dbn-/- SMCs had 1.7-fold higher levels of KLF4 and transdifferentiated to macrophage-like cells more readily than Dbnflox/flox SMCs upon cholesterol loading, as evidenced by greater up-regulation of CD68 and galectin-3. Adenovirally mediated Drebrin rescue produced equivalent levels of macrophage-like transdifferentiation in Dbn-/- and Dbnflox/flox SMCs. During early atherogenesis, SMC-Dbn-/-/Ldlr-/- aortas demonstrated 1.6-fold higher levels of reactive oxygen species than control mouse aortas. The 1.8-fold higher levels of Nox1 in Dbn-/- SMCs were reduced to WT levels with KLF4 silencing. Inhibition of Nox1 chemically or with siRNA produced equivalent levels of macrophage-like transdifferentiation in Dbn-/- and Dbnflox/flox SMCs.
We conclude that SMC Drebrin limits atherosclerosis by constraining SMC Nox1 activity and SMC transdifferentiation to macrophage-like cells.
Details
- Title: Subtitle
- Drebrin attenuates atherosclerosis by limiting smooth muscle cell transdifferentiation
- Creators
- Jiao-Hui Wu - Department of Medicine (Cardiology), Duke University Medical Center, 10 Duke Medicine Circle, Durham, NC 27710, USALisheng Zhang - Department of Medicine (Cardiology), Duke University Medical Center, 10 Duke Medicine Circle, Durham, NC 27710, USAIgor Nepliouev - Department of Medicine (Cardiology), Duke University Medical Center, 10 Duke Medicine Circle, Durham, NC 27710, USALeigh Brian - Department of Medicine (Cardiology), Duke University Medical Center, 10 Duke Medicine Circle, Durham, NC 27710, USATaiqin Huang - Department of Medicine (Cardiology), Duke University Medical Center, 10 Duke Medicine Circle, Durham, NC 27710, USAKamie P Snow - Department of Medicine (Cardiology), Duke University Medical Center, 10 Duke Medicine Circle, Durham, NC 27710, USABrandon M Schickling - Duke Medical CenterElizabeth R Hauser - Duke University School of MedicineFrancis J Miller - Atrium Health Wake Forest BaptistNeil J Freedman - Department of Medicine (Cardiology), Duke University Medical Center, 10 Duke Medicine Circle, Durham, NC 27710, USAJonathan A Stiber - Duke Medical Center
- Resource Type
- Journal article
- Publication Details
- Cardiovascular research, Vol.118(3), pp.772-784
- DOI
- 10.1093/cvr/cvab156
- PMID
- 33914863
- PMCID
- PMC8859638
- NLM abbreviation
- Cardiovasc Res
- ISSN
- 0008-6363
- eISSN
- 1755-3245
- Grant note
- R01 HL121531 / NHLBI NIH HHS T32 HL007101 / NHLBI NIH HHS R01 HL147157 / NHLBI NIH HHS
- Language
- English
- Date published
- 02/21/2022
- Academic Unit
- Obstetrics and Gynecology
- Record Identifier
- 9984966746702771
Metrics
1 Record Views